By Tony Winterburn • 02 April 2020 • 7:45
Benson and Hedges maker British American Tobacco (BAT) is developing a potential vaccine to combat the deadly coronavirus using tobacco plants and says it could produce three million doses a week by June.
THE company said: “If testing goes well, BAT is hopeful that, with the right partners and support from government agencies, between 1 million and 3 million doses of the vaccine could be manufactured per week, beginning in June.”
The company says it will begin clinical trials on humans soon and is currently running pre-clinical tests, the treatment is being developed by the company’s bio-health division, Kentucky BioProcessing (KBP).
KBP was one of the few firms that helped develop an effective treatment for Ebola in 2014.
The company claims to have found an antibody that appears to fight Covid-19, using genetically modified tobacco plants, urgent talks with US drug authorities to fast-track permissions.
Share this story
Subscribe to our Euro Weekly News alerts to get the latest stories into your inbox!
By signing up, you will create a Euro Weekly News account if you don’t already have one. Review our
Share your story with us by emailing [email protected], by calling +34 951 38 61 61 or by messaging our Facebook page www.facebook.com/EuroWeeklyNews
Your email address will not be published. Required fields are marked *
Download our media pack in either English or Spanish.